Effect of Milrinone in Patients with Rheumatic Heart Disease During Postoperative Drug Treatment
Objective:To investigate the effect of milrinone in patients with rheumatic heart disease during postoperative drug treatment.Methods:A total of 90 patients with rheumatic heart disease who underwent valvular angioplasty in the hospital from January 2021 to January 2023 were selected as the study subjects.They were divided into two groups according to the random number table method,with 45 patients in each group.The control group was treated with routine treatment,and the study group was treated with milrinone on the basis of routine treatment.The myocardial injury index,cardiac function index,sleep status index and quality of life score were compared between the two groups.Results:After treatment,troponin I,creatine kinase isoenzyme and lactate dehydrogenase in the study group were lower than those in the control group,and left ventricular ejection fraction,physiological score,psychological score,environmental score and social relationship score were higher than those in the control group,the differences were statistically significant(P<0.05).The total incidence of complications in the study group was 2.22%,which was lower than 15.56%in the control group,the difference was statistically significant(P<0.05).Conclusion:After valvuloplasty in patients with rheumatic heart disease,the application of milrinone for adjuvant therapy can enhance the cardiac function of patients,reduce their myocardial injury,and reduce the occurrence of complications,which is conducive to improving the quality of life.
Rheumatic heart diseaseValvuloplastyMillinonCardiac function